Can an antibody aid neuropsychiatric SLE diagnosis?

• by Kathryn Wighton

• August 27, 2026

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

• by Kathryn Wighton

• June 5, 2026

• 4 min

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

• by Meiwei Jiang, FengQi Zhang, MinZhe Ren, ZhiYu Li, ZhiJun Xie, Jing Sun

• June 10, 2026